AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 141 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $737,000 | +207.1% | 12,324 | +44.1% | 0.00% | – |
| Q3 2019 | $240,000 | -20.0% | 8,552 | +7.8% | 0.00% | – |
| Q2 2019 | $300,000 | +30.4% | 7,936 | +34.6% | 0.00% | – |
| Q1 2019 | $230,000 | -61.7% | 5,896 | -61.2% | 0.00% | -100.0% |
| Q3 2018 | $601,000 | -4.3% | 15,191 | -7.6% | 0.00% | 0.0% |
| Q2 2018 | $628,000 | -7.4% | 16,433 | -27.1% | 0.00% | 0.0% |
| Q1 2018 | $678,000 | -2.2% | 22,556 | +1.7% | 0.00% | 0.0% |
| Q4 2017 | $693,000 | +16.5% | 22,171 | +4.3% | 0.00% | 0.0% |
| Q3 2017 | $595,000 | -14.4% | 21,252 | -41.5% | 0.00% | 0.0% |
| Q2 2017 | $695,000 | +138.8% | 36,334 | +113.0% | 0.00% | – |
| Q1 2017 | $291,000 | -8.8% | 17,060 | -2.2% | 0.00% | – |
| Q4 2016 | $319,000 | -69.3% | 17,450 | -70.1% | 0.00% | -100.0% |
| Q3 2016 | $1,040,000 | – | 58,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
| Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
| Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
| Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
| Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
| Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
| Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
| Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
| Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |